Oxaceprol
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | D11AX09 (WHO) M01AX24 (WHO) |
Identifiers | |
| |
Synonyms | (2S,4R)-1-acetyl-4-hydroxypyrrolidine-2-carboxylic acid |
CAS Number | 33996-33-7 |
PubChem (CID) | 65784 |
ChemSpider | 59203 |
UNII | Q0XV76B96L |
KEGG | D07215 |
ChEMBL | CHEMBL1407356 |
ECHA InfoCard | 100.047.058 |
Chemical and physical data | |
Formula | C7H11NO4 |
Molar mass | 172.159 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
Oxaceprol is an anti-inflammatory drug used in the treatment of osteoarthritis.[1] It is derived from L-proline, a DNA-encoded amino acid. The active effect of Oxaceprol is to inhibit the adhesion and migration of white blood cells.[2]
References
- ↑ Herrmann G, Steeger D, Klasser M, et al. (2000). "Oxaceprol is a well-tolerated therapy for osteoarthritis with efficacy equivalent to diclofenac". Clin. Rheumatol. 19 (2): 99–104. doi:10.1007/s100670050025. PMID 10791619.
- ↑ Clayton, James J. (August 2007), "Nutraceuticals in the Management of Osteoarthritis", Orthopedics, 30 (8), retrieved 2013-06-08.
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.